Development of novel phosphodiesterase 5 inhibitors for the therapy of Alzheimer’s disease is a research paper published in Biochemical Pharmacology (2020). On theSindex it has a DataRank of 0.677. It has been cited 90 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.677
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institutes of Health
Grant: R01NS110024
National Institutes of Health
Grant: R01AG049402
NIH HHS
Grant: S10 OD018121
National Institutes of Health
Grant: 5R01NS110024-05
The Role of SUMOylation in Tau-Mediated Pathology
National Institutes of Health
Grant: 5R01AG049402-05
Extracellular tau oligomers and Alzheimer disease
Alzheimer's Association
FWCI
4.62
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals